Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Blood Cells Mol Dis. 2014 Mar 3;53(0):34–38. doi: 10.1016/j.bcmd.2014.02.002

Figure 2.

Figure 2

Influence of oral treatment of lethally-irradiated mouse recipients on engraftment of mouse BM cells in a short-term non-competitive assay. One hundred thousand B6.BoyJ (CD45.1+) donor cells were injected i.v. into C57Bl/6 (CD45.2+) recipient mice 24 hours after 950cGy radiation. The recipient mice were treated 4 hours after radiation with either oral administered control diluent or 200 μg sitagliptin. Results are shown as mean percent engraftment ±1SEM for 5 mice/group at one month post donor BM cell infusion with all mice surviving. a, significantly different from control treated recipients, p<0.001.